{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:38:38Z","timestamp":1789029518408,"version":"build-2803163510"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007176","name":"Scuola Superiore Sant'Anna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007176","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increased sympathetic and reduced parasympathetic nerve activity is associated with disease progression and poor outcomes in patients with chronic heart failure. The demonstration that markers of autonomic imbalance and vagal dysfunction, such as reduced heart rate variability and baroreflex sensitivity, hold prognostic value in patients with chronic heart failure despite modern therapies encourages the research for neuromodulation strategies targeting the vagus nerve. However, the approaches tested so far have yielded inconclusive results. This review aims to summarize the current knowledge about the role of the parasympathetic nervous system in chronic heart failure, describing the pathophysiological background, the methods of assessment, and the rationale, limits, and future perspectives of parasympathetic stimulation either by drugs or bioelectronic devices.<\/jats:p>","DOI":"10.1007\/s10741-024-10430-w","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T03:30:47Z","timestamp":1723174247000},"page":"1201-1215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treating heart failure by targeting the vagus nerve"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7453-3748","authenticated-orcid":false,"given":"Francesco","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Montuoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Fu","family":"Ferrari Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughan","family":"Macefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Passino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"10430_CR1","doi-asserted-by":"publisher","first-page":"617459","DOI":"10.3389\/fphys.2020.617459","volume":"11","author":"J Hadaya","year":"2020","unstructured":"Hadaya J, Ardell JL (2020) Autonomic modulation for cardiovascular disease. Front Physiol 11:617459. https:\/\/doi.org\/10.3389\/fphys.2020.617459","journal-title":"Front Physiol"},{"key":"10430_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S1566-0702(01)00274-0","volume":"90","author":"S Guzzetti","year":"2001","unstructured":"Guzzetti S, Magatelli R, Borroni E, Mezzetti S (2001) Heart rate variability in chronic heart failure. Auton Neurosci Basic Clin 90:102\u2013105. https:\/\/doi.org\/10.1016\/S1566-0702(01)00274-0","journal-title":"Auton Neurosci Basic Clin"},{"key":"10430_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0165-1838(98)00048-4","volume":"70","author":"LW Dickerson","year":"1998","unstructured":"Dickerson LW, Rodak DJ, Fleming TJ et al (1998) Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility. J Auton Nerv Syst 70:129\u2013141. https:\/\/doi.org\/10.1016\/s0165-1838(98)00048-4","journal-title":"J Auton Nerv Syst"},{"key":"10430_CR4","doi-asserted-by":"publisher","first-page":"e09","DOI":"10.15420\/cfr.2022.23","volume":"9","author":"V Castiglione","year":"2023","unstructured":"Castiglione V, Gentile F, Ghionzoli N et al (2023) Pathophysiological rationale and clinical evidence for neurohormonal modulation in heart failure with preserved ejection fraction. Card Fail Rev 9:e09. https:\/\/doi.org\/10.15420\/cfr.2022.23","journal-title":"Card Fail Rev"},{"key":"10430_CR5","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","volume":"78","author":"P Palau","year":"2021","unstructured":"Palau P, Seller J, Dom\u00ednguez E et al (2021) Effect of \u03b2-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction. J Am Coll Cardiol 78:2042\u20132056. https:\/\/doi.org\/10.1016\/j.jacc.2021.08.073","journal-title":"J Am Coll Cardiol"},{"key":"10430_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jacbts.2021.11.007","volume":"7","author":"DM Kaye","year":"2022","unstructured":"Kaye DM, Nanayakkara S, Wang B et al (2022) Characterization of cardiac sympathetic nervous system and inflammatory activation in HFpEF patients. JACC Basic Transl Sci 7:116\u2013127. https:\/\/doi.org\/10.1016\/j.jacbts.2021.11.007","journal-title":"JACC Basic Transl Sci"},{"key":"10430_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1161\/HYPERTENSIONAHA.123.21918","volume":"81","author":"R Takeda","year":"1979","unstructured":"Takeda R, Hissen SL, Akins JD et al (1979) (2024) Sympathetic neural control at rest and during the cold pressor test in patients with heart failure with preserved ejection fraction. Hypertens Dallas Tex 81:917\u2013926. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21918","journal-title":"Hypertens Dallas Tex"},{"key":"10430_CR8","doi-asserted-by":"publisher","first-page":"e024481","DOI":"10.1161\/JAHA.121.024481","volume":"11","author":"V Kittipibul","year":"2022","unstructured":"Kittipibul V, Fudim M (2022) Tackling inflammation in heart failure with preserved ejection fraction: resurrection of vagus nerve stimulation? J Am Heart Assoc 11:e024481. https:\/\/doi.org\/10.1161\/JAHA.121.024481","journal-title":"J Am Heart Assoc"},{"key":"10430_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jchf.2022.02.006","volume":"10","author":"A Giannoni","year":"2022","unstructured":"Giannoni A, Gentile F, Buoncristiani F et al (2022) Chemoreflex and baroreflex sensitivity hold a strong prognostic value in chronic heart failure. JACC Heart Fail 10:662\u2013676. https:\/\/doi.org\/10.1016\/j.jchf.2022.02.006","journal-title":"JACC Heart Fail"},{"key":"10430_CR10","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/ejhf.921","volume":"19","author":"M van Bilsen","year":"2017","unstructured":"van Bilsen M, Patel HC, Bauersachs J et al (2017) The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 19:1361\u20131378. https:\/\/doi.org\/10.1002\/ejhf.921","journal-title":"Eur J Heart Fail"},{"key":"10430_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2119\/molmed.2014.00125","volume":"20","author":"A Roy","year":"2015","unstructured":"Roy A, Guatimosim S, Prado VF et al (2015) Cholinergic activity as a new target in diseases of the heart. Mol Med Camb Mass 20:527\u2013537. https:\/\/doi.org\/10.2119\/molmed.2014.00125","journal-title":"Mol Med Camb Mass"},{"key":"10430_CR12","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/ejhf.2627","volume":"24","author":"F Gentile","year":"2022","unstructured":"Gentile F, Passino C, Emdin M, Giannoni A (2022) Baroreflex activation therapy in heart failure: targeting the right patient. Eur J Heart Fail 24:1674\u20131676. https:\/\/doi.org\/10.1002\/ejhf.2627","journal-title":"Eur J Heart Fail"},{"key":"10430_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cardfail.2020.12.017","volume":"27","author":"TW Dasari","year":"2021","unstructured":"Dasari TW, Csipo T, Amil F et al (2021) Effects of low-level tragus stimulation on endothelial function in heart failure with reduced ejection fraction. J Card Fail 27:568\u2013576. https:\/\/doi.org\/10.1016\/j.cardfail.2020.12.017","journal-title":"J Card Fail"},{"key":"10430_CR14","doi-asserted-by":"publisher","first-page":"e023582","DOI":"10.1161\/JAHA.121.023582","volume":"11","author":"S Stavrakis","year":"2022","unstructured":"Stavrakis S, Elkholey K, Morris L et al (2022) Neuromodulation of inflammation to treat heart failure with preserved ejection fraction: a pilot randomized clinical trial. J Am Heart Assoc 11:e023582. https:\/\/doi.org\/10.1161\/JAHA.121.023582","journal-title":"J Am Heart Assoc"},{"key":"10430_CR15","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1113\/JP271870","volume":"594","author":"K Shivkumar","year":"2016","unstructured":"Shivkumar K, Ajijola OA, Anand I et al (2016) Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. J Physiol 594:3911\u20133954. https:\/\/doi.org\/10.1113\/JP271870","journal-title":"J Physiol"},{"key":"10430_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0079-6123(08)61859-2","volume":"107","author":"DA Hopkins","year":"1996","unstructured":"Hopkins DA, Bieger D, deVente J, Steinbusch WM (1996) Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Prog Brain Res 107:79\u201396. https:\/\/doi.org\/10.1016\/s0079-6123(08)61859-2","journal-title":"Prog Brain Res"},{"key":"10430_CR17","doi-asserted-by":"publisher","first-page":"R703","DOI":"10.1152\/ajpregu.1988.255.5.R703","volume":"255","author":"DM Plecha","year":"1988","unstructured":"Plecha DM, Randall WC, Geis GS, Wurster RD (1988) Localization of vagal preganglionic somata controlling sinoatrial and atrioventricular nodes. Am J Physiol 255:R703-708. https:\/\/doi.org\/10.1152\/ajpregu.1988.255.5.R703","journal-title":"Am J Physiol"},{"key":"10430_CR18","doi-asserted-by":"publisher","first-page":"866957","DOI":"10.3389\/fcvm.2022.866957","volume":"9","author":"MM Ottaviani","year":"2022","unstructured":"Ottaviani MM, Vallone F, Micera S, Recchia FA (2022) Closed-loop vagus nerve stimulation for the treatment of cardiovascular diseases: state of the art and future directions. Front Cardiovasc Med 9:866957. https:\/\/doi.org\/10.3389\/fcvm.2022.866957","journal-title":"Front Cardiovasc Med"},{"key":"10430_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1161\/01.cir.85.4.1311","volume":"85","author":"MD Carlson","year":"1992","unstructured":"Carlson MD, Geha AS, Hsu J et al (1992) Selective stimulation of parasympathetic nerve fibers to the human sinoatrial node. Circulation 85:1311\u20131317. https:\/\/doi.org\/10.1161\/01.cir.85.4.1311","journal-title":"Circulation"},{"key":"10430_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0165-1838(95)00104-2","volume":"57","author":"PJ Gatti","year":"1996","unstructured":"Gatti PJ, Johnson TA, Massari VJ (1996) Can neurons in the nucleus ambiguus selectively regulate cardiac rate and atrio-ventricular conduction? J Auton Nerv Syst 57:123\u2013127. https:\/\/doi.org\/10.1016\/0165-1838(95)00104-2","journal-title":"J Auton Nerv Syst"},{"key":"10430_CR21","doi-asserted-by":"publisher","first-page":"665298","DOI":"10.3389\/fphys.2021.665298","volume":"12","author":"TE Zandstra","year":"2021","unstructured":"Zandstra TE, Notenboom RGE, Wink J et al (2021) Asymmetry and heterogeneity: part and parcel in cardiac autonomic innervation and function. Front Physiol 12:665298. https:\/\/doi.org\/10.3389\/fphys.2021.665298","journal-title":"Front Physiol"},{"key":"10430_CR22","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1113\/JP271869","volume":"594","author":"JL Ardell","year":"2016","unstructured":"Ardell JL, Andresen MC, Armour JA et al (2016) Translational neurocardiology: preclinical models and cardioneural integrative aspects. J Physiol 594:3877\u20133909. https:\/\/doi.org\/10.1113\/JP271869","journal-title":"J Physiol"},{"key":"10430_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0165-1838(89)90170-7","volume":"26","author":"DA Hopkins","year":"1989","unstructured":"Hopkins DA, Armour JA (1989) Ganglionic distribution of afferent neurons innervating the canine heart and cardiopulmonary nerves. J Auton Nerv Syst 26:213\u2013222. https:\/\/doi.org\/10.1016\/0165-1838(89)90170-7","journal-title":"J Auton Nerv Syst"},{"key":"10430_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1113\/jphysiol.1953.sp004920","volume":"120","author":"AS Paintal","year":"1953","unstructured":"Paintal AS (1953) A study of right and left atrial receptors. J Physiol 120:596\u2013610. https:\/\/doi.org\/10.1113\/jphysiol.1953.sp004920","journal-title":"J Physiol"},{"key":"10430_CR25","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/00000542-200305000-00030","volume":"98","author":"JA Campagna","year":"2003","unstructured":"Campagna JA, Carter C (2003) Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology 98:1250\u20131260. https:\/\/doi.org\/10.1097\/00000542-200305000-00030","journal-title":"Anesthesiology"},{"key":"10430_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1113\/jphysiol.1979.sp012915","volume":"294","author":"ER Lumbers","year":"1979","unstructured":"Lumbers ER, McCloskey DI, Potter EK (1979) Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol 294:69\u201380. https:\/\/doi.org\/10.1113\/jphysiol.1979.sp012915","journal-title":"J Physiol"},{"key":"10430_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.resp.2011.05.016","volume":"178","author":"JF Thayer","year":"2011","unstructured":"Thayer JF, Loerbroks A, Sternberg EM (2011) Inflammation and cardiorespiratory control: the role of the vagus nerve. Respir Physiol Neurobiol 178:387\u2013394. https:\/\/doi.org\/10.1016\/j.resp.2011.05.016","journal-title":"Respir Physiol Neurobiol"},{"key":"10430_CR28","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1113\/JP271539","volume":"594","author":"B Bonaz","year":"2016","unstructured":"Bonaz B, Sinniger V, Pellissier S (2016) Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol 594:5781\u20135790. https:\/\/doi.org\/10.1113\/JP271539","journal-title":"J Physiol"},{"key":"10430_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/jcdd7040054","volume":"7","author":"L Fedele","year":"2020","unstructured":"Fedele L, Brand T (2020) The intrinsic cardiac nervous system and its role in cardiac pacemaking and conduction. J Cardiovasc Dev Dis 7:54. https:\/\/doi.org\/10.3390\/jcdd7040054","journal-title":"J Cardiovasc Dev Dis"},{"key":"10430_CR30","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/CIRCRESAHA.116.304679","volume":"116","author":"K Fukuda","year":"2015","unstructured":"Fukuda K, Kanazawa H, Aizawa Y et al (2015) Cardiac innervation and sudden cardiac death. Circ Res 116:2005\u20132019. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304679","journal-title":"Circ Res"},{"key":"10430_CR31","first-page":"279","volume":"50","author":"MP Caulfield","year":"1998","unstructured":"Caulfield MP, Birdsall NJ (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279\u2013290","journal-title":"Pharmacol Rev"},{"key":"10430_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/298576a0","volume":"298","author":"W Osterrieder","year":"1982","unstructured":"Osterrieder W, Brum G, Hescheler J et al (1982) Injection of subunits of cyclic AMP-dependent protein kinase into cardiac myocytes modulates Ca2+ current. Nature 298:576\u2013578. https:\/\/doi.org\/10.1038\/298576a0","journal-title":"Nature"},{"key":"10430_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.2916119","volume":"243","author":"D DiFrancesco","year":"1989","unstructured":"DiFrancesco D, Ducouret P, Robinson RB (1989) Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science 243:669\u2013671. https:\/\/doi.org\/10.1126\/science.2916119","journal-title":"Science"},{"key":"10430_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00581906","volume":"410","author":"D DiFrancesco","year":"1987","unstructured":"DiFrancesco D, Tromba C (1987) Acetylcholine inhibits activation of the cardiac hyperpolarizing-activated current, if. Pflugers Arch 410:139\u2013142. https:\/\/doi.org\/10.1007\/BF00581906","journal-title":"Pflugers Arch"},{"key":"10430_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/325321a0","volume":"325","author":"DE Logothetis","year":"1987","unstructured":"Logothetis DE, Kurachi Y, Galper J et al (1987) The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 325:321\u2013326. https:\/\/doi.org\/10.1038\/325321a0","journal-title":"Nature"},{"key":"10430_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/phrs.2001.0835","volume":"44","author":"S Dhein","year":"2001","unstructured":"Dhein S, van Koppen CJ, Brodde OE (2001) Muscarinic receptors in the mammalian heart. Pharmacol Res 44:161\u2013182. https:\/\/doi.org\/10.1006\/phrs.2001.0835","journal-title":"Pharmacol Res"},{"key":"10430_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00424-012-1075-1","volume":"463","author":"DV Abramochkin","year":"2012","unstructured":"Abramochkin DV, Tapilina SV, Sukhova GS et al (2012) Functional M3 cholinoreceptors are present in pacemaker and working myocardium of murine heart. Pflugers Arch 463:523\u2013529. https:\/\/doi.org\/10.1007\/s00424-012-1075-1","journal-title":"Pflugers Arch"},{"key":"10430_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/01.res.79.1.86","volume":"79","author":"VK Sharma","year":"1996","unstructured":"Sharma VK, Colecraft HM, Wang DX et al (1996) Molecular and functional identification of m1 muscarinic acetylcholine receptors in rat ventricular myocytes. Circ Res 79:86\u201393. https:\/\/doi.org\/10.1161\/01.res.79.1.86","journal-title":"Circ Res"},{"key":"10430_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1113\/jphysiol.2003.052449","volume":"553","author":"SG Lechner","year":"2003","unstructured":"Lechner SG, Mayer M, Boehm S (2003) Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels. J Physiol 553:789\u2013802. https:\/\/doi.org\/10.1113\/jphysiol.2003.052449","journal-title":"J Physiol"},{"key":"10430_CR40","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCULATIONAHA.107.760405","volume":"118","author":"B Olshansky","year":"2008","unstructured":"Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS (2008) Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118:863\u2013871. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.760405","journal-title":"Circulation"},{"key":"10430_CR41","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00210-012-0740-4","volume":"385","author":"S Wang","year":"2012","unstructured":"Wang S, Han H, Pan Z et al (2012) Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway. Naunyn Schmiedebergs Arch Pharmacol 385:823\u2013831. https:\/\/doi.org\/10.1007\/s00210-012-0740-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10430_CR42","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3389\/fphar.2019.01386","volume":"10","author":"L Zhao","year":"2019","unstructured":"Zhao L, Chen T, Hang P et al (2019) Choline attenuates cardiac fibrosis by inhibiting p38MAPK signaling possibly by acting on M3 muscarinic acetylcholine receptor. Front Pharmacol 10:1386. https:\/\/doi.org\/10.3389\/fphar.2019.01386","journal-title":"Front Pharmacol"},{"key":"10430_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF03402177","volume":"9","author":"VA Pavlov","year":"2003","unstructured":"Pavlov VA, Wang H, Czura CJ et al (2003) The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9:125\u2013134","journal-title":"Mol Med"},{"key":"10430_CR44","doi-asserted-by":"publisher","first-page":"104622","DOI":"10.1016\/j.neubiorev.2022.104622","volume":"136","author":"NV Alen","year":"2022","unstructured":"Alen NV (2022) The cholinergic anti-inflammatory pathway in humans: state-of-the-art review and future directions. Neurosci Biobehav Rev 136:104622. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104622","journal-title":"Neurosci Biobehav Rev"},{"key":"10430_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1365-2796.2004.01442.x","volume":"257","author":"CJ Czura","year":"2005","unstructured":"Czura CJ, Tracey KJ (2005) Autonomic neural regulation of immunity. J Intern Med 257:156\u2013166. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01442.x","journal-title":"J Intern Med"},{"key":"10430_CR46","doi-asserted-by":"publisher","first-page":"C155","DOI":"10.1152\/ajpcell.00315.2020","volume":"320","author":"C Rocha-Resende","year":"2021","unstructured":"Rocha-Resende C, da Silva AM, Prado MAM, Guatimosim S (2021) Protective and anti-inflammatory effects of acetylcholine in the heart. Am J Physiol Cell Physiol 320:C155\u2013C161. https:\/\/doi.org\/10.1152\/ajpcell.00315.2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"21","key":"10430_CR47","doi-asserted-by":"publisher","first-page":"00050","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"S1071\u20139164","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H et al (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail S1071\u20139164(21):00050\u201300056. https:\/\/doi.org\/10.1016\/j.cardfail.2021.01.022","journal-title":"J Card Fail"},{"key":"10430_CR48","doi-asserted-by":"publisher","first-page":"R541","DOI":"10.1152\/ajpregu.1998.275.2.R541","volume":"275","author":"T Nakahara","year":"1998","unstructured":"Nakahara T, Kawada T, Sugimachi M et al (1998) Cholinesterase affects dynamic transduction properties from vagal stimulation to heart rate. Am J Physiol 275:R541-547. https:\/\/doi.org\/10.1152\/ajpregu.1998.275.2.R541","journal-title":"Am J Physiol"},{"key":"10430_CR49","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1556\/650.2020.31780","volume":"161","author":"R Urbancsek","year":"2020","unstructured":"Urbancsek R, Forg\u00e1cs IN, Papp TB et al (2020) Theory and history of the study of muscle sympathetic nerve activity. Orv Hetil 161:1190\u20131199. https:\/\/doi.org\/10.1556\/650.2020.31780","journal-title":"Orv Hetil"},{"key":"10430_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1365-201X.2003.01089.x","volume":"177","author":"M Esler","year":"2003","unstructured":"Esler M, Lambert G, Brunner-La Rocca HP et al (2003) Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 177:275\u2013284. https:\/\/doi.org\/10.1046\/j.1365-201X.2003.01089.x","journal-title":"Acta Physiol Scand"},{"key":"10430_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1113\/jphysiol.1992.sp019217","volume":"453","author":"BG Wallin","year":"1992","unstructured":"Wallin BG, Esler M, Dorward P et al (1992) Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 453:45\u201358. https:\/\/doi.org\/10.1113\/jphysiol.1992.sp019217","journal-title":"J Physiol"},{"key":"10430_CR52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00125-003-1032-9","volume":"46","author":"J Gerritsen","year":"2003","unstructured":"Gerritsen J, TenVoorde BJ, Dekker JM et al (2003) Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects. Diabetologia 46:330\u2013338. https:\/\/doi.org\/10.1007\/s00125-003-1032-9","journal-title":"Diabetologia"},{"key":"10430_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2337\/diacare.8.5.491","volume":"8","author":"DJ Ewing","year":"1985","unstructured":"Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:491\u2013498. https:\/\/doi.org\/10.2337\/diacare.8.5.491","journal-title":"Diabetes Care"},{"key":"10430_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s1388-9842(00)00119-7","volume":"3","author":"G Tjeerdsma","year":"2001","unstructured":"Tjeerdsma G, Szab\u00f3 BM, van Wijk LM et al (2001) Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade. Eur J Heart Fail 3:33\u201339. https:\/\/doi.org\/10.1016\/s1388-9842(00)00119-7","journal-title":"Eur J Heart Fail"},{"key":"10430_CR55","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","volume":"93","author":"Electrophysiology, Task Force of the European Society of Cardiology the North American Society of Pacing","year":"1996","unstructured":"Electrophysiology, Task Force of the European Society of Cardiology the North American Society of Pacing (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043\u20131065. https:\/\/doi.org\/10.1161\/01.CIR.93.5.1043","journal-title":"Circulation"},{"key":"10430_CR56","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/europace\/euv015","volume":"17","author":"R Sassi","year":"2015","unstructured":"Sassi R, Cerutti S, Lombardi F et al (2015) Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 17:1341\u20131353. https:\/\/doi.org\/10.1093\/europace\/euv015","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10430_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1542-474X.2005.10101.x","volume":"10","author":"RE Kleiger","year":"2005","unstructured":"Kleiger RE, Stein PK, Bigger JT (2005) Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol Off J Int Soc Holter Noninvasive Electrocardiol Inc 10:88\u2013101. https:\/\/doi.org\/10.1111\/j.1542-474X.2005.10101.x","journal-title":"Ann Noninvasive Electrocardiol Off J Int Soc Holter Noninvasive Electrocardiol Inc"},{"key":"10430_CR58","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1540-8167.2006.00501.x","volume":"17","author":"KC Bilchick","year":"2006","unstructured":"Bilchick KC, Berger RD (2006) Heart rate variability. J Cardiovasc Electrophysiol 17:691\u2013694. https:\/\/doi.org\/10.1111\/j.1540-8167.2006.00501.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10430_CR59","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","volume":"59","author":"RE Kleiger","year":"1987","unstructured":"Kleiger RE, Miller JP, Bigger JT, Moss AJ (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59:256\u2013262. https:\/\/doi.org\/10.1016\/0002-9149(87)90795-8","journal-title":"Am J Cardiol"},{"key":"10430_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1109\/10.477700","volume":"43","author":"S Pola","year":"1996","unstructured":"Pola S, Macerata A, Emdin M, Marchesi C (1996) Estimation of the power spectral density in nonstationary cardiovascular time series: assessing the role of the time-frequency representations (TFR). IEEE Trans Biomed Eng 43:46\u201359. https:\/\/doi.org\/10.1109\/10.477700","journal-title":"IEEE Trans Biomed Eng"},{"key":"10430_CR61","doi-asserted-by":"publisher","first-page":"e160721189770","DOI":"10.2174\/1573403X16999201231203854","volume":"17","author":"R Tiwari","year":"2021","unstructured":"Tiwari R, Kumar R, Malik S et al (2021) Analysis of heart rate variability and implication of different factors on heart rate variability. Curr Cardiol Rev 17:e160721189770. https:\/\/doi.org\/10.2174\/1573403X16999201231203854","journal-title":"Curr Cardiol Rev"},{"key":"10430_CR62","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev.ph.42.030180.002241","volume":"42","author":"DE Donald","year":"1980","unstructured":"Donald DE, Shepherd JT (1980) Autonomic regulation of the peripheral circulation. Annu Rev Physiol 42:429\u2013439. https:\/\/doi.org\/10.1146\/annurev.ph.42.030180.002241","journal-title":"Annu Rev Physiol"},{"key":"10430_CR63","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/HJH.0b013e32832a6e1b","volume":"27","author":"M Milic","year":"2009","unstructured":"Milic M, Sun P, Liu F et al (2009) A comparison of pharmacologic and spontaneous baroreflex methods in aging and hypertension. J Hypertens 27:1243\u20131251. https:\/\/doi.org\/10.1097\/HJH.0b013e32832a6e1b","journal-title":"J Hypertens"},{"key":"10430_CR64","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/j.1552-4604.1994.tb04977.x","volume":"34","author":"JJ Smith","year":"1994","unstructured":"Smith JJ, Porth CM, Erickson M (1994) Hemodynamic response to the upright posture. J Clin Pharmacol 34:375\u2013386. https:\/\/doi.org\/10.1002\/j.1552-4604.1994.tb04977.x","journal-title":"J Clin Pharmacol"},{"key":"10430_CR65","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/s0140-6736(97)11144-8","volume":"351","author":"MT La Rovere","year":"1998","unstructured":"La Rovere MT, Bigger JT, Marcus FI et al (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet Lond Engl 351:478\u2013484. https:\/\/doi.org\/10.1016\/s0140-6736(97)11144-8","journal-title":"Lancet Lond Engl"},{"key":"10430_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2008.09.034","volume":"53","author":"MT La Rovere","year":"2009","unstructured":"La Rovere MT, Pinna GD, Maestri R et al (2009) Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 53:193\u2013199. https:\/\/doi.org\/10.1016\/j.jacc.2008.09.034","journal-title":"J Am Coll Cardiol"},{"key":"10430_CR67","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1542-474X.2008.00219.x","volume":"13","author":"MT La Rovere","year":"2008","unstructured":"La Rovere MT, Pinna GD, Raczak G (2008) Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol Off J Int Soc Holter Noninvasive Electrocardiol Inc 13:191\u2013207. https:\/\/doi.org\/10.1111\/j.1542-474X.2008.00219.x","journal-title":"Ann Noninvasive Electrocardiol Off J Int Soc Holter Noninvasive Electrocardiol Inc"},{"key":"10430_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10286-010-0079-1","volume":"20","author":"L Bernardi","year":"2010","unstructured":"Bernardi L, De Barbieri G, Roseng\u00e5rd-B\u00e4rlund M et al (2010) New method to measure and improve consistency of baroreflex sensitivity values. Clin Auton Res Off J Clin Auton Res Soc 20:353\u2013361. https:\/\/doi.org\/10.1007\/s10286-010-0079-1","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"issue":"Pt 1","key":"10430_CR69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1113\/jphysiol.1995.sp020585","volume":"483","author":"JA Taylor","year":"1995","unstructured":"Taylor JA, Halliwill JR, Brown TE et al (1995) \u201cNon-hypotensive\u201d hypovolaemia reduces ascending aortic dimensions in humans. J Physiol 483(Pt 1):289\u2013298. https:\/\/doi.org\/10.1113\/jphysiol.1995.sp020585","journal-title":"J Physiol"},{"key":"10430_CR70","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1113\/JP280077","volume":"598","author":"MM Ottaviani","year":"2020","unstructured":"Ottaviani MM, Wright L, Dawood T, Macefield VG (2020) In vivo recordings from the human vagus nerve using ultrasound-guided microneurography. J Physiol 598:3569\u20133576. https:\/\/doi.org\/10.1113\/JP280077","journal-title":"J Physiol"},{"key":"10430_CR71","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1113\/JP282994","volume":"600","author":"M Patros","year":"2022","unstructured":"Patros M, Ottaviani MM, Wright L et al (2022) Quantification of cardiac and respiratory modulation of axonal activity in the human vagus nerve. J Physiol 600:3113\u20133126. https:\/\/doi.org\/10.1113\/JP282994","journal-title":"J Physiol"},{"key":"10430_CR72","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-l","volume":"20","author":"M Packer","year":"1992","unstructured":"Packer M (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20:248\u2013254. https:\/\/doi.org\/10.1016\/0735-1097(92)90167-l","journal-title":"J Am Coll Cardiol"},{"key":"10430_CR73","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/eurheartj\/ehv087","volume":"36","author":"JS Floras","year":"2015","unstructured":"Floras JS, Ponikowski P (2015) The sympathetic\/parasympathetic imbalance in heart failure with reduced ejection fraction. Eur Heart J 36:1974\u20131982b. https:\/\/doi.org\/10.1093\/eurheartj\/ehv087","journal-title":"Eur Heart J"},{"key":"10430_CR74","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1540-8159.2004.00431.x","volume":"27","author":"R Arora","year":"2004","unstructured":"Arora R, Krummerman A, Vijayaraman P et al (2004) Heart rate variability and diastolic heart failure. Pacing Clin Electrophysiol PACE 27:299\u2013303. https:\/\/doi.org\/10.1111\/j.1540-8159.2004.00431.x","journal-title":"Pacing Clin Electrophysiol PACE"},{"key":"10430_CR75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/HJH.0000000000001856","volume":"37","author":"G Seravalle","year":"2019","unstructured":"Seravalle G, Quarti-Trevano F, Dell\u2019Oro R et al (2019) Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. J Hypertens 37:443\u2013448. https:\/\/doi.org\/10.1097\/HJH.0000000000001856","journal-title":"J Hypertens"},{"key":"10430_CR76","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cjca.2020.12.006","volume":"37","author":"MB Badrov","year":"2021","unstructured":"Badrov MB, Mak S, Floras JS (2021) Cardiovascular autonomic disturbances in heart failure with preserved ejection fraction. Can J Cardiol 37:609\u2013620. https:\/\/doi.org\/10.1016\/j.cjca.2020.12.006","journal-title":"Can J Cardiol"},{"key":"10430_CR77","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/oxfordjournals.eurheartj.a061053","volume":"16","author":"S Guzzetti","year":"1995","unstructured":"Guzzetti S, Cogliati C, Turiel M et al (1995) Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J 16:1100\u20131107. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a061053","journal-title":"Eur Heart J"},{"key":"10430_CR78","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/s0002-9149(96)00199-3","volume":"77","author":"P Ponikowski","year":"1996","unstructured":"Ponikowski P, Chua TP, Amadi AA et al (1996) Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failure. Am J Cardiol 77:1320\u20131326. https:\/\/doi.org\/10.1016\/s0002-9149(96)00199-3","journal-title":"Am J Cardiol"},{"key":"10430_CR79","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/euhj.1999.1875","volume":"21","author":"M Galinier","year":"2000","unstructured":"Galinier M, Pathak A, Fourcade J et al (2000) Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 21:475\u2013482. https:\/\/doi.org\/10.1053\/euhj.1999.1875","journal-title":"Eur Heart J"},{"key":"10430_CR80","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/01.cir.95.6.1449","volume":"95","author":"P van de Borne","year":"1997","unstructured":"van de Borne P, Montano N, Pagani M et al (1997) Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95:1449\u20131454. https:\/\/doi.org\/10.1161\/01.cir.95.6.1449","journal-title":"Circulation"},{"key":"10430_CR81","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJM198207223070401","volume":"307","author":"MR Bristow","year":"1982","unstructured":"Bristow MR, Ginsburg R, Minobe W et al (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205\u2013211. https:\/\/doi.org\/10.1056\/NEJM198207223070401","journal-title":"N Engl J Med"},{"key":"10430_CR82","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cardfail.2019.08.012","volume":"25","author":"ME Dunlap","year":"2019","unstructured":"Dunlap ME, Kinugawa T, Sica DA, Thames MD (2019) Cardiopulmonary baroreflex control of renal sympathetic nerve activity is impaired in dogs with left ventricular dysfunction. J Card Fail 25:819\u2013827. https:\/\/doi.org\/10.1016\/j.cardfail.2019.08.012","journal-title":"J Card Fail"},{"key":"10430_CR83","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10741-019-09901-2","volume":"26","author":"G Grassi","year":"2021","unstructured":"Grassi G, Quarti-Trevano F, Esler MD (2021) Sympathetic activation in congestive heart failure: an updated overview. Heart Fail Rev 26:173\u2013182. https:\/\/doi.org\/10.1007\/s10741-019-09901-2","journal-title":"Heart Fail Rev"},{"key":"10430_CR84","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1113\/JP272318","volume":"594","author":"BK Becker","year":"2016","unstructured":"Becker BK, Tian C, Zucker IH, Wang H-J (2016) Influence of brain-derived neurotrophic factor-tyrosine receptor kinase B signalling in the nucleus tractus solitarius on baroreflex sensitivity in rats with chronic heart failure. J Physiol 594:5711\u20135725. https:\/\/doi.org\/10.1113\/JP272318","journal-title":"J Physiol"},{"key":"10430_CR85","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ajh\/hpv141","volume":"29","author":"Y-L Li","year":"2016","unstructured":"Li Y-L, Zhang D, Tu H, Muelleman RL (2016) Altered ENaC is associated with aortic baroreceptor dysfunction in chronic heart failure. Am J Hypertens 29:582\u2013589. https:\/\/doi.org\/10.1093\/ajh\/hpv141","journal-title":"Am J Hypertens"},{"key":"10430_CR86","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12264-018-0274-y","volume":"35","author":"H Tu","year":"2019","unstructured":"Tu H, Zhang D, Li Y-L (2019) Cellular and molecular mechanisms underlying arterial baroreceptor remodeling in cardiovascular diseases and diabetes. Neurosci Bull 35:98\u2013112. https:\/\/doi.org\/10.1007\/s12264-018-0274-y","journal-title":"Neurosci Bull"},{"key":"10430_CR87","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s1388-9842(02)00010-7","volume":"4","author":"ALP Caforio","year":"2002","unstructured":"Caforio ALP, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 4:411\u2013417. https:\/\/doi.org\/10.1016\/s1388-9842(02)00010-7","journal-title":"Eur J Heart Fail"},{"key":"10430_CR88","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/s0735-1097(02)01865-x","volume":"39","author":"HR Liu","year":"2002","unstructured":"Liu HR, Zhao RR, Jiao XY et al (2002) Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta(1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J Am Coll Cardiol 39:1866\u20131873. https:\/\/doi.org\/10.1016\/s0735-1097(02)01865-x","journal-title":"J Am Coll Cardiol"},{"key":"10430_CR89","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/01.cir.94.1.102","volume":"94","author":"DE Vatner","year":"1996","unstructured":"Vatner DE, Sato N, Galper JB, Vatner SF (1996) Physiological and biochemical evidence for coordinate increases in muscarinic receptors and Gi during pacing-induced heart failure. Circulation 94:102\u2013107. https:\/\/doi.org\/10.1161\/01.cir.94.1.102","journal-title":"Circulation"},{"key":"10430_CR90","doi-asserted-by":"publisher","first-page":"H1632","DOI":"10.1152\/ajpheart.01051.2002","volume":"285","author":"ME Dunlap","year":"2003","unstructured":"Dunlap ME, Bibevski S, Rosenberry TL, Ernsberger P (2003) Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. Am J Physiol Heart Circ Physiol 285:H1632-1640. https:\/\/doi.org\/10.1152\/ajpheart.01051.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10430_CR91","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10741-010-9190-6","volume":"16","author":"S Bibevski","year":"2011","unstructured":"Bibevski S, Dunlap ME (2011) Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev 16:129\u2013135. https:\/\/doi.org\/10.1007\/s10741-010-9190-6","journal-title":"Heart Fail Rev"},{"key":"10430_CR92","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1161\/01.cir.99.22.2958","volume":"99","author":"S Bibevski","year":"1999","unstructured":"Bibevski S, Dunlap ME (1999) Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation 99:2958\u20132963. https:\/\/doi.org\/10.1161\/01.cir.99.22.2958","journal-title":"Circulation"},{"key":"10430_CR93","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/s0735-1097(00)00900-1","volume":"36","author":"A Mortara","year":"2000","unstructured":"Mortara A, La Rovere MT, Pinna GD et al (2000) Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroreflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol 36:1612\u20131618. https:\/\/doi.org\/10.1016\/s0735-1097(00)00900-1","journal-title":"J Am Coll Cardiol"},{"key":"10430_CR94","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","volume":"29","author":"AJ Miller","year":"2019","unstructured":"Miller AJ, Arnold AC (2019) The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clin Auton Res Off J Clin Auton Res Soc 29:231\u2013243. https:\/\/doi.org\/10.1007\/s10286-018-0572-5","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"10430_CR95","unstructured":"Abstract 13303: snfluence of ARNI on cardiac autonomic nervous system | Circulation. https:\/\/www.ahajournals.org\/doi\/10.1161\/circ.146.suppl_1.13303. Accessed 22 Jan 2024"},{"key":"10430_CR96","doi-asserted-by":"publisher","first-page":"832","DOI":"10.5152\/AnatolJCardiol.2022.1934","volume":"26","author":"AS Balc\u0131o\u011flu","year":"2022","unstructured":"Balc\u0131o\u011flu AS, \u00c7elik E, \u015eahin M et al (2022) Dapagliflozin improves cardiac autonomic function measures in type 2 diabetic patients with cardiac autonomic neuropathy. Anatol J Cardiol 26:832\u2013840. https:\/\/doi.org\/10.5152\/AnatolJCardiol.2022.1934","journal-title":"Anatol J Cardiol"},{"key":"10430_CR97","doi-asserted-by":"publisher","first-page":"e13396","DOI":"10.1111\/apha.13396","volume":"228","author":"T Khuanjing","year":"2020","unstructured":"Khuanjing T, Palee S, Chattipakorn SC, Chattipakorn N (2020) The effects of acetylcholinesterase inhibitors on the heart in acute myocardial infarction and heart failure: From cells to patient reports. Acta Physiol Oxf Engl 228:e13396. https:\/\/doi.org\/10.1111\/apha.13396","journal-title":"Acta Physiol Oxf Engl"},{"key":"10430_CR98","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/heart.89.8.854","volume":"89","author":"AS Androne","year":"2003","unstructured":"Androne AS, Hryniewicz K, Goldsmith R et al (2003) Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart Br Card Soc 89:854\u2013858. https:\/\/doi.org\/10.1136\/heart.89.8.854","journal-title":"Heart Br Card Soc"},{"key":"10430_CR99","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cardfail.2008.10.018","volume":"15","author":"SM Serra","year":"2009","unstructured":"Serra SM, Costa RV, Teixeira De Castro RR et al (2009) Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. J Card Fail 15:124\u2013129. https:\/\/doi.org\/10.1016\/j.cardfail.2008.10.018","journal-title":"J Card Fail"},{"key":"10430_CR100","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0002-8703(03)00319-3","volume":"146","author":"A Behling","year":"2003","unstructured":"Behling A, Moraes RS, Rohde LE et al (2003) Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am Heart J 146:494\u2013500. https:\/\/doi.org\/10.1016\/S0002-8703(03)00319-3","journal-title":"Am Heart J"},{"key":"10430_CR101","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1074248418799364","volume":"24","author":"AS Villacorta","year":"2019","unstructured":"Villacorta AS, Villacorta H, Caldas JA et al (2019) Effects of heart rate reduction with either pyridostigmine or ivabradine in patients with heart failure: a randomized, double-blind study. J Cardiovasc Pharmacol Ther 24:139\u2013145. https:\/\/doi.org\/10.1177\/1074248418799364","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10430_CR102","doi-asserted-by":"publisher","first-page":"831730","DOI":"10.3389\/fcvm.2022.831730","volume":"9","author":"M-J Hsieh","year":"2022","unstructured":"Hsieh M-J, Chen D-Y, Lee C-H et al (2022) Association between cholinesterase inhibitors and new-onset heart failure in patients with Alzheimer\u2019s disease: a nationwide propensity score matching study. Front Cardiovasc Med 9:831730. https:\/\/doi.org\/10.3389\/fcvm.2022.831730","journal-title":"Front Cardiovasc Med"},{"key":"10430_CR103","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.amjcard.2023.05.041","volume":"200","author":"L Rampa","year":"2023","unstructured":"Rampa L, Santangelo R, Gaspardone C et al (2023) Potential cardiologic protective effects of acetylcholinesterase inhibitors in patients with mild to moderate dementia. Am J Cardiol 200:162\u2013170. https:\/\/doi.org\/10.1016\/j.amjcard.2023.05.041","journal-title":"Am J Cardiol"},{"key":"10430_CR104","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0167-5273(98)00335-0","volume":"68","author":"T Hayano","year":"1999","unstructured":"Hayano T, Shimizu A, Ikeda Y et al (1999) Paradoxical effects of pirenzepine on parasympathetic activity in chronic heart failure and control. Int J Cardiol 68:47\u201356. https:\/\/doi.org\/10.1016\/s0167-5273(98)00335-0","journal-title":"Int J Cardiol"},{"key":"10430_CR105","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/hrt.76.2.137","volume":"76","author":"G Venkatesh","year":"1996","unstructured":"Venkatesh G, Fallen EL, Kamath MV et al (1996) Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure. Heart Br Card Soc 76:137\u2013143. https:\/\/doi.org\/10.1136\/hrt.76.2.137","journal-title":"Heart Br Card Soc"},{"key":"10430_CR106","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.cir.90.2.838","volume":"90","author":"MT La Rovere","year":"1994","unstructured":"La Rovere MT, Mortara A, Pantaleo P et al (1994) Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation 90:838\u2013843. https:\/\/doi.org\/10.1161\/01.cir.90.2.838","journal-title":"Circulation"},{"key":"10430_CR107","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/hrt.75.3.274","volume":"75","author":"B Casadei","year":"1996","unstructured":"Casadei B, Conway J, Forfar C, Sleight P (1996) Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart Br Card Soc 75:274\u2013280. https:\/\/doi.org\/10.1136\/hrt.75.3.274","journal-title":"Heart Br Card Soc"},{"key":"10430_CR108","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0735-1097(94)00468-6","volume":"25","author":"RF Pedretti","year":"1995","unstructured":"Pedretti RF, Colombo E, Sarzi Braga S et al (1995) Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. J Am Coll Cardiol 25:915\u2013921. https:\/\/doi.org\/10.1016\/0735-1097(94)00468-6","journal-title":"J Am Coll Cardiol"},{"key":"10430_CR109","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ejheart.2008.07.016","volume":"10","author":"PJ Schwartz","year":"2008","unstructured":"Schwartz PJ, De Ferrari GM, Sanzo A et al (2008) Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 10:884\u2013891. https:\/\/doi.org\/10.1016\/j.ejheart.2008.07.016","journal-title":"Eur J Heart Fail"},{"key":"10430_CR110","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/jce.12850","volume":"27","author":"M Chen","year":"2016","unstructured":"Chen M, Zhou X, Yu L et al (2016) Low-level vagus nerve stimulation attenuates myocardial ischemic reperfusion injury by antioxidative stress and antiapoptosis reactions in canines. J Cardiovasc Electrophysiol 27:224\u2013231. https:\/\/doi.org\/10.1111\/jce.12850","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10430_CR111","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12265-014-9540-1","volume":"7","author":"GM De Ferrari","year":"2014","unstructured":"De Ferrari GM (2014) Vagal stimulation in heart failure. J Cardiovasc Transl Res 7:310\u2013320. https:\/\/doi.org\/10.1007\/s12265-014-9540-1","journal-title":"J Cardiovasc Transl Res"},{"key":"10430_CR112","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ijcard.2015.07.083","volume":"199","author":"M Chen","year":"2015","unstructured":"Chen M, Yu L, Zhou X et al (2015) Low-level vagus nerve stimulation: an important therapeutic option for atrial fibrillation treatment via modulating cardiac autonomic tone. Int J Cardiol 199:437\u2013438. https:\/\/doi.org\/10.1016\/j.ijcard.2015.07.083","journal-title":"Int J Cardiol"},{"key":"10430_CR113","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehq391","volume":"32","author":"GM De Ferrari","year":"2011","unstructured":"De Ferrari GM, Crijns HJGM, Borggrefe M et al (2011) Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J 32:847\u2013855. https:\/\/doi.org\/10.1093\/eurheartj\/ehq391","journal-title":"Eur Heart J"},{"key":"10430_CR114","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cardfail.2014.08.009","volume":"20","author":"RK Premchand","year":"2014","unstructured":"Premchand RK, Sharma K, Mittal S et al (2014) Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail 20:808\u2013816. https:\/\/doi.org\/10.1016\/j.cardfail.2014.08.009","journal-title":"J Card Fail"},{"key":"10430_CR115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/eurheartj\/ehu345","volume":"36","author":"F Zannad","year":"2015","unstructured":"Zannad F, De Ferrari GM, Tuinenburg AE et al (2015) Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J 36:425\u2013433. https:\/\/doi.org\/10.1093\/eurheartj\/ehu345","journal-title":"Eur Heart J"},{"key":"10430_CR116","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jacc.2016.03.525","volume":"68","author":"MR Gold","year":"2016","unstructured":"Gold MR, Van Veldhuisen DJ, Hauptman PJ et al (2016) Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol 68:149\u2013158. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.525","journal-title":"J Am Coll Cardiol"},{"key":"10430_CR117","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijcard.2023.03.030","volume":"381","author":"HU Kumar","year":"2023","unstructured":"Kumar HU, Nearing BD, Mittal S et al (2023) Autonomic regulation therapy in chronic heart failure with preserved\/mildly reduced ejection fraction: ANTHEM-HFpEF study results. Int J Cardiol 381:37\u201344. https:\/\/doi.org\/10.1016\/j.ijcard.2023.03.030","journal-title":"Int J Cardiol"},{"issue":"23","key":"10430_CR118","doi-asserted-by":"publisher","first-page":"00064","DOI":"10.1016\/j.tcm.2023.07.003","volume":"S1050\u20131738","author":"S Zafeiropoulos","year":"2023","unstructured":"Zafeiropoulos S, Ahmed U, Bikou A et al (2023) Vagus nerve stimulation for cardiovascular diseases: is there light at the end of the tunnel? Trends Cardiovasc Med S1050\u20131738(23):00064\u201300066. https:\/\/doi.org\/10.1016\/j.tcm.2023.07.003","journal-title":"Trends Cardiovasc Med"},{"key":"10430_CR119","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/joa.13122","volume":"236","author":"MF Butt","year":"2020","unstructured":"Butt MF, Albusoda A, Farmer AD, Aziz Q (2020) The anatomical basis for transcutaneous auricular vagus nerve stimulation. J Anat 236:588\u2013611. https:\/\/doi.org\/10.1111\/joa.13122","journal-title":"J Anat"},{"key":"10430_CR120","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.brs.2017.05.006","volume":"10","author":"D Antonino","year":"2017","unstructured":"Antonino D, Teixeira AL, Maia-Lopes PM et al (2017) Non-invasive vagus nerve stimulation acutely improves spontaneous cardiac baroreflex sensitivity in healthy young men: a randomized placebo-controlled trial. Brain Stimulat 10:875\u2013881. https:\/\/doi.org\/10.1016\/j.brs.2017.05.006","journal-title":"Brain Stimulat"},{"key":"10430_CR121","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.18632\/aging.102074","volume":"11","author":"B Bretherton","year":"2019","unstructured":"Bretherton B, Atkinson L, Murray A et al (2019) Effects of transcutaneous vagus nerve stimulation in individuals aged 55 years or above: potential benefits of daily stimulation. Aging 11:4836\u20134857. https:\/\/doi.org\/10.18632\/aging.102074","journal-title":"Aging"},{"key":"10430_CR122","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10286-023-00938-w","volume":"33","author":"D Soltani","year":"2023","unstructured":"Soltani D, Azizi B, Sima S et al (2023) A systematic review of the effects of transcutaneous auricular vagus nerve stimulation on baroreflex sensitivity and heart rate variability in healthy subjects. Clin Auton Res Off J Clin Auton Res Soc 33:165\u2013189. https:\/\/doi.org\/10.1007\/s10286-023-00938-w","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"10430_CR123","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.brs.2014.07.031","volume":"7","author":"JA Clancy","year":"2014","unstructured":"Clancy JA, Mary DA, Witte KK et al (2014) Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimulat 7:871\u2013877. https:\/\/doi.org\/10.1016\/j.brs.2014.07.031","journal-title":"Brain Stimulat"},{"key":"10430_CR124","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001564","volume":"7","author":"Z Wang","year":"2014","unstructured":"Wang Z, Yu L, Wang S et al (2014) Chronic intermittent low-level transcutaneous electrical stimulation of auricular branch of vagus nerve improves left ventricular remodeling in conscious dogs with healed myocardial infarction. Circ Heart Fail 7:1014\u20131021. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001564","journal-title":"Circ Heart Fail"},{"key":"10430_CR125","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacep.2015.11.006","volume":"2","author":"L Yu","year":"2016","unstructured":"Yu L, Wang S, Zhou X et al (2016) Chronic intermittent low-level stimulation of tragus reduces cardiac autonomic remodeling and ventricular arrhythmia inducibility in a post-infarction canine model. JACC Clin Electrophysiol 2:330\u2013339. https:\/\/doi.org\/10.1016\/j.jacep.2015.11.006","journal-title":"JACC Clin Electrophysiol"},{"key":"10430_CR126","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.jcin.2017.04.036","volume":"10","author":"L Yu","year":"2017","unstructured":"Yu L, Huang B, Po SS et al (2017) Low-level tragus stimulation for the treatment of ischemia and reperfusion injury in patients with ST-segment elevation myocardial infarction: a proof-of-concept study. JACC Cardiovasc Interv 10:1511\u20131520. https:\/\/doi.org\/10.1016\/j.jcin.2017.04.036","journal-title":"JACC Cardiovasc Interv"},{"key":"10430_CR127","doi-asserted-by":"publisher","first-page":"e009288","DOI":"10.1161\/CIRCHEARTFAILURE.122.009288","volume":"15","author":"K Elkholey","year":"2022","unstructured":"Elkholey K, Niewiadomska M, Morris L et al (2022) Transcutaneous vagus nerve stimulation ameliorates the phenotype of heart failure with preserved ejection fraction through its anti-inflammatory effects. Circ Heart Fail 15:e009288. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.009288","journal-title":"Circ Heart Fail"},{"key":"10430_CR128","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10354-014-0329-2","volume":"164","author":"J Schmidli","year":"1946","unstructured":"Schmidli J, von Allmen RS (1946) Mohaupt MG (2014) Electrical carotid baroreceptor stimulation. Wien Med Wochenschr 164:508\u2013514. https:\/\/doi.org\/10.1007\/s10354-014-0329-2","journal-title":"Wien Med Wochenschr"},{"key":"10430_CR129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14740\/cr1330","volume":"13","author":"N Babar","year":"2022","unstructured":"Babar N, Giedrimiene D (2022) Updates on baroreflex activation therapy and vagus nerve stimulation for treatment of heart failure with reduced ejection fraction. Cardiol Res 13:11\u201317. https:\/\/doi.org\/10.14740\/cr1330","journal-title":"Cardiol Res"},{"key":"10430_CR130","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Zile MR, Weaver FA et al (2015) Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail 3:487\u2013496. https:\/\/doi.org\/10.1016\/j.jchf.2015.02.006","journal-title":"JACC Heart Fail"},{"key":"10430_CR131","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ejhf.299","volume":"17","author":"MR Zile","year":"2015","unstructured":"Zile MR, Abraham WT, Weaver FA et al (2015) Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. Eur J Heart Fail 17:1066\u20131074. https:\/\/doi.org\/10.1002\/ejhf.299","journal-title":"Eur J Heart Fail"},{"key":"10430_CR132","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"10430_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3232","author":"MR Zile","year":"2024","unstructured":"Zile MR, Lindenfeld J, Weaver FA et al (2024) Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: long-term outcomes. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3232","journal-title":"Eur J Heart Fail"},{"key":"10430_CR134","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.shj.2022.100086","volume":"6","author":"K Piayda","year":"2022","unstructured":"Piayda K, Sievert K, Sievert H et al (2022) Endovascular baroreflex amplification with the MobiusHD device in patients with heart failure and reduced ejection fraction: interim analysis of the first-in-human results. Struct Heart J Heart Team 6:100086. https:\/\/doi.org\/10.1016\/j.shj.2022.100086","journal-title":"Struct Heart J Heart Team"},{"key":"10430_CR135","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jchf.2015.11.007","volume":"4","author":"GA Upadhyay","year":"2016","unstructured":"Upadhyay GA, Singh JP (2016) Spinal cord stimulation for heart failure in the DEFEAT-HF study: lost battle or lasting opportunities? JACC Heart Fail 4:137\u2013139. https:\/\/doi.org\/10.1016\/j.jchf.2015.11.007","journal-title":"JACC Heart Fail"},{"key":"10430_CR136","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1161\/CIRCULATIONAHA.104.507897","volume":"111","author":"ZF Issa","year":"2005","unstructured":"Issa ZF, Zhou X, Ujhelyi MR et al (2005) Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model. Circulation 111:3217\u20133220. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.507897","journal-title":"Circulation"},{"key":"10430_CR137","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1540-8167.2011.02230.x","volume":"23","author":"Y Liu","year":"2012","unstructured":"Liu Y, Yue W-S, Liao S-Y et al (2012) Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure. J Cardiovasc Electrophysiol 23:534\u2013540. https:\/\/doi.org\/10.1111\/j.1540-8167.2011.02230.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10430_CR138","doi-asserted-by":"publisher","unstructured":"From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA), Congress of Neurological Surgeons (CNS), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Society for Cardiovascular Angiography and Interventions (SCAI), Society of Interventional Radiology (SIR), Society of NeuroInterventional Surgery (SNIS), and World Stroke Organization (WSO), Sacks D, Baxter B et al (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke Off J Int Stroke Soc 13:612\u2013632. https:\/\/doi.org\/10.1177\/1747493018778713","DOI":"10.1177\/1747493018778713"},{"key":"10430_CR139","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jchf.2015.10.006","volume":"4","author":"DP Zipes","year":"2016","unstructured":"Zipes DP, Neuzil P, Theres H et al (2016) Determining the feasibility of spinal cord neuromodulation for the treatment of chronic systolic heart failure: the DEFEAT-HF study. JACC Heart Fail 4:129\u2013136. https:\/\/doi.org\/10.1016\/j.jchf.2015.10.006","journal-title":"JACC Heart Fail"},{"key":"10430_CR140","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1161\/01.cir.85.6.2119","volume":"85","author":"AJ Coats","year":"1992","unstructured":"Coats AJ, Adamopoulos S, Radaelli A et al (1992) Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85:2119\u20132131. https:\/\/doi.org\/10.1161\/01.cir.85.6.2119","journal-title":"Circulation"},{"key":"10430_CR141","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/01.cir.0000027565.12764.e1","volume":"106","author":"MT La Rovere","year":"2002","unstructured":"La Rovere MT, Bersano C, Gnemmi M et al (2002) Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 106:945\u2013949. https:\/\/doi.org\/10.1161\/01.cir.0000027565.12764.e1","journal-title":"Circulation"},{"key":"10430_CR142","doi-asserted-by":"publisher","first-page":"638","DOI":"10.4103\/ijmr.IJMR_559_19","volume":"152","author":"B Anasuya","year":"2020","unstructured":"Anasuya B, Deepak KK, Jaryal AK, Narang R (2020) Effect of slow breathing on autonomic tone & baroreflex sensitivity in yoga practitioners. Indian J Med Res 152:638\u2013647. https:\/\/doi.org\/10.4103\/ijmr.IJMR_559_19","journal-title":"Indian J Med Res"},{"key":"10430_CR143","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(00)02881-6","volume":"356","author":"L Spicuzza","year":"2000","unstructured":"Spicuzza L, Gabutti A, Porta C et al (2000) Yoga and chemoreflex response to hypoxia and hypercapnia. Lancet Lond Engl 356:1495\u20131496. https:\/\/doi.org\/10.1016\/S0140-6736(00)02881-6","journal-title":"Lancet Lond Engl"},{"key":"10430_CR144","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/1474515119863181","volume":"18","author":"J Viveiros","year":"2019","unstructured":"Viveiros J, Chamberlain B, O\u2019Hare A, Sethares KA (2019) Meditation interventions among heart failure patients: an integrative review. Eur J Cardiovasc Nurs 18:720\u2013728. https:\/\/doi.org\/10.1177\/1474515119863181","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10430_CR145","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/acm.2005.11.465","volume":"11","author":"JA Curiati","year":"2005","unstructured":"Curiati JA, Bocchi E, Freire JO et al (2005) Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study. J Altern Complement Med N Y N 11:465\u2013472. https:\/\/doi.org\/10.1089\/acm.2005.11.465","journal-title":"J Altern Complement Med N Y N"},{"key":"10430_CR146","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7860\/JCDR\/2014\/7844.3983","volume":"8","author":"BH Krishna","year":"2014","unstructured":"Krishna BH, Pal P, G K P, et al (2014) Effect of yoga therapy on heart rate, blood pressure and cardiac autonomic function in heart failure. J Clin Diagn Res JCDR 8:14\u201316. https:\/\/doi.org\/10.7860\/JCDR\/2014\/7844.3983","journal-title":"J Clin Diagn Res JCDR"},{"key":"10430_CR147","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/PHM.0000000000000723","volume":"96","author":"Q Gu","year":"2017","unstructured":"Gu Q, Wu S-J, Zheng Y et al (2017) Tai chi exercise for patients with chronic heart failure: a meta-analysis of randomized controlled trials. Am J Phys Med Rehabil 96:706\u2013716. https:\/\/doi.org\/10.1097\/PHM.0000000000000723","journal-title":"Am J Phys Med Rehabil"},{"key":"10430_CR148","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1093\/eurheartj\/ehac343","volume":"43","author":"A Giannoni","year":"2022","unstructured":"Giannoni A, Gentile F, Passino C (2022) Bioelectronic medicine and its applications in cardiology. Eur Heart J 43:4453\u20134455. https:\/\/doi.org\/10.1093\/eurheartj\/ehac343","journal-title":"Eur Heart J"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10430-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T19:03:14Z","timestamp":1728154994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10430-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":148,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["10430"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10430-w","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"28 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}